Progyny, Inc. Announces Participation at the Goldman Sachs Healthcare Conference

Rhea-AI Summary

Progyny, Inc. (Nasdaq: PGNY), a leader in fertility benefits management, announced participation in the Goldman Sachs 41st Annual Global Healthcare Conference on June 9, 2020. CEO David Schlanger and President Pete Anevski will join a fireside chat at 4:40 P.M. Eastern Time. Progyny aims to redefine fertility benefits, offering solutions that include dedicated Patient Care Advocates and access to a network of specialists. Recognized as a CNBC 50 Disruptor and among the fastest-growing companies, Progyny continues to innovate in family building benefits.

Positive

• Participation in high-profile conference, enhancing visibility and credibility.
• Recognition as a leader in the fertility benefits sector, indicated by accolades from CNBC and Financial Times.

Negative

• None.

NEW YORK, June 04, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Pete Anevski, President, Chief Financial and Operating Officer, will participate in a fireside chat at the Goldman Sachs 41st Annual Global Healthcare Conference on Tuesday, June 9, 2020 at 4:40 P.M. Eastern Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.

About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians. 

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been named a CNBC 50 Disruptor for three years in a row, to the INC. 5000, Crain’s Fast 50 for NYC, and Modern Healthcare’s Best Places to Work in Healthcare for two years in a row, and Financial Times’ Fastest Growing Companies in the Americas. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com

FAQ

What is Progyny's stock symbol?

Progyny's stock symbol is PGNY.

When will Progyny participate in the Goldman Sachs conference?

Progyny will participate in the Goldman Sachs conference on June 9, 2020, at 4:40 P.M. Eastern Time.

Who are the Progyny executives participating in the conference?

David Schlanger, CEO, and Pete Anevski, President, will participate in the conference.

What benefits does Progyny provide?

Progyny provides fertility and family building benefits solutions, including education and access to fertility specialists.

What accolades has Progyny received?

Progyny has been recognized as a CNBC 50 Disruptor and is listed among the fastest-growing companies by Financial Times.